Innovation Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch IPIX and buy or sell other stocks, ETFs, and their options commission-free!

About IPIX

Innovation Pharmaceuticals, Inc. is a clinical stage biotechnology company, which engages in the development of therapies with anti-infective, oncology, anti-inflammatory, and dermatology applications. It focuses on its antifungal drug candidate called Brilacidin. 

CEO
Leo Ehrlich
CEOLeo Ehrlich
Employees
4
Employees4
Headquarters
Wakefield, Massachusetts
HeadquartersWakefield, Massachusetts
Founded
2007
Founded2007
Employees
4
Employees4

IPIX Key Statistics

Market cap
53.73K
Market cap53.73K
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
87.26K
Average volume87.26K
High today
$0.0039
High today$0.0039
Low today
$0.0001
Low today$0.0001
Open price
$0.0001
Open price$0.0001
Volume
305.50K
Volume305.50K
52 Week high
$0.05
52 Week high$0.05
52 Week low
$0.00
52 Week low$0.00

Stock Snapshot

Innovation Pharmaceuticals(IPIX) stock is priced at $0.00, giving the company a market capitalization of 53.73K.

During the trading session on 2026-04-29, Innovation Pharmaceuticals(IPIX) shares reached a daily high of $0.00 and a low of $0.00. At a current price of $0.00, the stock is 0.0% higher than the low and still -97.4% under the high.

Trading volume for Innovation Pharmaceuticals(IPIX) stock has reached 305.5K, versus its average volume of 87.26K.

The stock's 52-week range extends from a low of $0.00 to a high of $0.05.

The stock's 52-week range extends from a low of $0.00 to a high of $0.05.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.